Heart Failure Clinical Trial

Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure

Summary

Observational study of elderly individuals diagnosed with Non-Valvular Atrial Fibrillation and Heart Failure who are beginning oral blood thinners

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Were age greater than or equal to 65 years as of the index date
Had greater than or equal to 1 diagnosis of AF prior to or on the index date
Had greater than or equal to 1 diagnosis claim of HF during the 12 months prior to or on the index date
Had 1 or more pharmacy claim for oral blood thinners

Exclusion Criteria:

Claims indicating diagnosis or procedure for hip/knee replacement surgery within 6 weeks prior to index date
Pharmacy claim for warfarin, apixaban, dabigatran, edoxaban or rivaroxaban during the 12-month baseline period
Greater than 1 oral anticoagulants prescription claim on the index date and/or with a follow-up less than 1 day
Had medical claim indicating VTE in the 12 months prior to index date

Other protocol defined inclusion/exclusion criteria could apply

Study is for people with:

Heart Failure

Estimated Enrollment:

60000

Study ID:

NCT03508271

Recruitment Status:

Completed

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Local Institution
Ann Arbor Michigan, 48104, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

60000

Study ID:

NCT03508271

Recruitment Status:

Completed

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider